BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38192816)

  • 1. ANP32B promotes colorectal cancer cell progression and reduces cell sensitivity to PRAP1 inhibitor through up-regulating HPF1.
    Yang LL; Li M; Huang W; Ren PT; Yan QH; Hao YH
    Heliyon; 2024 Jan; 10(1):e23829. PubMed ID: 38192816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANP32B promotes lung cancer progression by regulating VDAC1.
    Li T; Wang N; Li S; Yan H; Gao S; Gao W; Xu R
    Gene; 2023 Apr; 859():147200. PubMed ID: 36642319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic Leucine-Rich Nuclear Protein Phosphatase 32B Promotes Prostate Adenocarcinoma Cell Progression by Regulating Apoptosis and Epithelial-Mesenchymal Transition.
    A M; Wang L; Xue Y; Wang C
    Altern Ther Health Med; 2024 Feb; ():. PubMed ID: 38401083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPF1 regulates tendon stem/progenitor cell senescence and tendon repair via PARP1-mediated poly-ADP ribosylation of HuR.
    Han W; Gu D; Chen H; Tao X; Chen L
    Genes Genomics; 2024 Jan; 46(1):27-36. PubMed ID: 37713069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
    Rudolph J; Roberts G; Muthurajan UM; Luger K
    Elife; 2021 Mar; 10():. PubMed ID: 33683197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
    Ohno Y; Koizumi M; Nakayama H; Watanabe T; Hirooka M; Tokumoto Y; Kuroda T; Abe M; Fukuda S; Higashiyama S; Kumagi T; Hiasa Y
    PLoS One; 2017; 12(5):e0177343. PubMed ID: 28486557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) contributes to retinoic acid-induced differentiation of leukemic cells.
    Yu Y; Shen SM; Zhang FF; Wu ZX; Han B; Wang LS
    Biochem Biophys Res Commun; 2012 Jul; 423(4):721-5. PubMed ID: 22705300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency.
    Stojanovic P; Luger K; Rudolph J
    Biochemistry; 2023 Aug; 62(16):2382-2390. PubMed ID: 37531469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation.
    Yang S; Zhou L; Reilly PT; Shen SM; He P; Zhu XN; Li CX; Wang LS; Mak TW; Chen GQ; Yu Y
    Cell Death Dis; 2016 Feb; 7(2):e2082. PubMed ID: 26844697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylation.
    Wan X; Wang J; Fang F; Hu Y; Zhang Z; Tao Y; Zhang Y; Yu J; Wu Y; Zhou B; Yin H; Ma L; Li X; Zhuo R; Cheng W; Zhang S; Pan J; Lu J; Hu S
    Cancer Cell Int; 2024 Feb; 24(1):81. PubMed ID: 38383388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice.
    Yang Q; Liu HR; Yang S; Wei YS; Zhu XN; Zhi Z; Zhu D; Chen GQ; Yu Y
    Cancer Sci; 2023 Jul; 114(7):2882-2894. PubMed ID: 37137487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the PP2A activity by the histone chaperone ANP32B is long-range allosterically regulated by respiratory cytochrome c.
    Rivero-Rodríguez F; Díaz-Quintana A; Velázquez-Cruz A; González-Arzola K; Gavilan MP; Velázquez-Campoy A; Ríos RM; De la Rosa MA; Díaz-Moreno I
    Redox Biol; 2021 Jul; 43():101967. PubMed ID: 33882408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.
    Li CX; Shen SM; Wang LS; Yu Y
    Mol Med Rep; 2015 Apr; 11(4):2813-8. PubMed ID: 25483709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
    Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
    Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
    Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
    Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
    Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
    Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of host cellular factor ANP32B with matrix proteins of different paramyxoviruses.
    Günther M; Bauer A; Müller M; Zaeck L; Finke S
    J Gen Virol; 2020 Jan; 101(1):44-58. PubMed ID: 31793855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANP32B is a nuclear target of henipavirus M proteins.
    Bauer A; Neumann S; Karger A; Henning AK; Maisner A; Lamp B; Dietzel E; Kwasnitschka L; Balkema-Buschmann A; Keil GM; Finke S
    PLoS One; 2014; 9(5):e97233. PubMed ID: 24823948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.